Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 9Gastrointestinal 6CNS 6Tumor-Agnostic 4Thoracic 4Other hematologic neoplasm 4Genitourinary 3Lymphoid 2Head & Neck 2Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1

Conditions

Teratoma, Ovarian 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Dysgerminoma 1Brenner Tumor 1

Interventions

Surveys and Questionnaires 58Blood Specimen Collection 31Surgical Procedures, Operative 13Interviews as Topic 13Immunohistochemistry 13Data Collection 13niraparib 12Hyperthermic Intraperitoneal Chemotherapy 11Observation 10Drug Therapy 10Cytoreduction Surgical Procedures 10Magnetic Resonance Spectroscopy 9Radiotherapy 8Polymerase Chain Reaction 8Papanicolaou Test 8Colposcopy 8Cisplatin 8Biopsy 8Amplified Fragment Length Polymorphism Analysis 8olaparib 7Carboplatin 7Ultrasonography 6Sentinel Lymph Node Biopsy 6Psychiatric Rehabilitation 6Paclitaxel 6Microarray Analysis 6Laparoscopy 6Hysterectomy 6DNA Methylation 6liposomal doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Mental Status and Dementia Tests × Gynecologic × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡